https://european-biotechnology.net/wp-content/uploads/2025/08/Lab-31-e1755511169870-1030x580-1.png5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-08-18 10:02:342025-08-18 10:02:34Anocca raises €38.4m to advance TCR-T leads vs. pancreatic cancer
https://european-biotechnology.net/wp-content/uploads/2025/08/EdiMembre-e1755672266386.png468831Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-08-18 06:53:512025-08-18 06:53:51Merck and mantro enter the foodtech market
https://european-biotechnology.net/wp-content/uploads/2025/08/IO-Biotech-ASCO-2025-Cover-Image-e1754920785505-1030x581-1.jpg5811030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-08-11 14:00:262025-08-11 19:02:02IO Biotech’s cancer jab falls short in Phase 3, but Danish firm still eyes FDA approval
https://european-biotechnology.net/wp-content/uploads/2025/08/EU-Biotech-Act_1299854022_oynRQWpc8YPprtvb5tO9Tcqvgwp8kDJO-e1754461928206.jpg5631000Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-08-06 06:34:072025-08-06 06:34:07EU Biotech Act: Have your say!
